Dragovich and co-workers (Pillow et al., 2019) constructed 10 (Figure 5A) using a disulfide linker, which selectively targeted the acute myeloid leukemia (AML) tumors by C-type lectin-like molecule-1 (CLL1) antigen-dependent delivery. The gene discussed is CLEC12A; the disease is acute myeloid leukemia.